Home | Post –authorizacion study on safety and effectiveness of ior®EPOCIM of 3000 UI y 5000 UI in patients with symptomatic anemia associated chronic kidney disease undergoing dialysis.

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Post –authorizacion study on safety and effectiveness of ior®EPOCIM of 3000 UI y 5000 UI in patients with symptomatic anemia associated chronic kidney disease undergoing dialysis. has 2 revisions.
RevisionStatus
Saved 28/10/2026 - 1:48pm by CIM
current revision (published)
Saved 28/10/2026 - 1:45pm by CIM
archived